Literature DB >> 18584241

Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma.

Hilmar Kuehl1, Joerg Stattaus, Michael Forsting, Gerald Antoch.   

Abstract

The prognosis of patients with adrenal metastases from hepatocellular carcinoma (HCC) has been poor, and aggressive treatment of these tumors is mandatory to improve patients' survival. Since adrenalectomy may be difficult to perform after previous surgery of the right liver lobe, other approaches are required to treat the adrenal mass. This report aims at demonstrating the feasibility of CT-guided transhepatic radiofrequency ablation of right adrenal HCC metastases pretreated with chemoembolization in patients unable to undergo surgical resection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584241     DOI: 10.1007/s00270-008-9377-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Transarterial embolization of metastatic mediastinal hepatocellular carcinoma.

Authors:  Chia-Chang Chen; Hong-Zen Yeh; Chi-Sen Chang; Chung-Wang Ko; Han-Chung Lien; Chun-Ying Wu; Siu-Wan Hung
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy : Efficacy and outcome.

Authors:  K Mohnike; K Neumann; P Hass; M Seidensticker; R Seidensticker; M Pech; S Klose; T Streitparth; B Garlipp; C Benckert; J J Wendler; U B Liehr; M Schostak; D Göppner; G Gademann; J Ricke
Journal:  Strahlenther Onkol       Date:  2017-03-24       Impact factor: 3.621

3.  Multimodality non-rigid image registration for planning, targeting and monitoring during CT-guided percutaneous liver tumor cryoablation.

Authors:  Haytham Elhawary; Sota Oguro; Kemal Tuncali; Paul R Morrison; Servet Tatli; Paul B Shyn; Stuart G Silverman; Nobuhiko Hata
Journal:  Acad Radiol       Date:  2010-11       Impact factor: 3.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.